Drug and disease signature integration identifies synergistic combinations in glioblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Drug and disease signature integration identifies synergistic combinations in glioblastoma ; volume:9 ; number:1 ; day:14 ; month:12 ; year:2018 ; pages:1-13 ; date:12.2018
Nature Communications ; 9, Heft 1 (14.12.2018), 1-13, 12.2018
- Creator
-
Stathias, Vasileios
Jermakowicz, Anna M.
Maloof, Marie E.
Forlin, Michele
Walters, Winston
Suter, Robert K.
Durante, Michael A.
Williams, Sion L.
Harbour, J. William
Volmar, Claude-Henry
Lyons, Nicholas J.
Wahlestedt, Claes
Graham, Regina M.
Ivan, Michael E.
Komotar, Ricardo J.
Sarkaria, Jann N.
Subramanian, Aravind
Golub, Todd R.
Schürer, Stephan C.
Ayad, Nagi G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-07659-z
- URN
-
urn:nbn:de:101:1-2019012722324199599578
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stathias, Vasileios
- Jermakowicz, Anna M.
- Maloof, Marie E.
- Forlin, Michele
- Walters, Winston
- Suter, Robert K.
- Durante, Michael A.
- Williams, Sion L.
- Harbour, J. William
- Volmar, Claude-Henry
- Lyons, Nicholas J.
- Wahlestedt, Claes
- Graham, Regina M.
- Ivan, Michael E.
- Komotar, Ricardo J.
- Sarkaria, Jann N.
- Subramanian, Aravind
- Golub, Todd R.
- Schürer, Stephan C.
- Ayad, Nagi G.
- SpringerLink (Online service)
Other Objects (12)
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
piscesCSM: prediction of anticancer synergistic drug combinations
CD95 identifies glioblastoma stem cells
A connectivity signature for glioblastoma [Abstract]
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Synergistic Anti-Dermatophytic Potential of Nanoparticles and Essential Oils Combinations
Prediction of synergistic drug combinations using PCA-initialized deep learning
Predicting anticancer synergistic drug combinations based on multi-task learning
A review on graph neural networks for predicting synergistic drug combinations
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
piscesCSM: prediction of anticancer synergistic drug combinations
CD95 identifies glioblastoma stem cells
A connectivity signature for glioblastoma [Abstract]
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Synergistic Anti-Dermatophytic Potential of Nanoparticles and Essential Oils Combinations
Prediction of synergistic drug combinations using PCA-initialized deep learning
Predicting anticancer synergistic drug combinations based on multi-task learning
A review on graph neural networks for predicting synergistic drug combinations
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
piscesCSM: prediction of anticancer synergistic drug combinations
CD95 identifies glioblastoma stem cells
A connectivity signature for glioblastoma [Abstract]
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Synergistic Anti-Dermatophytic Potential of Nanoparticles and Essential Oils Combinations
Prediction of synergistic drug combinations using PCA-initialized deep learning
Predicting anticancer synergistic drug combinations based on multi-task learning